Quick Takeaways
- ARK Investment Management LLC filed SCHEDULE 13G/A for Beam Therapeutics Inc. Common Stock (BEAM).
- Disclosed ownership: 7.9%.
- Date of event: 30 Sep 2024.
ARK Investment Management LLC - 30 Sep 2024 SCHEDULE 13G/A Report for Beam Therapeutics Inc. Common Stock (BEAM)
- Filing Manager
- ARK Investment Management LLC
- Reporting Manager
- ARK Investment Management LLC
- Security
- Beam Therapeutics Inc. Common Stock
- Symbol
- BEAM
- Shares outstanding
- 82,463,371 shares
- Disclosed Ownership
- 6,531,099 shares
- Ownership
- 7.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 10 Jan 2025, 21:46:00 UTC
- Date of event
- 30 Sep 2024
- Next filing
- 07 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ARK Investment Management LLC disclosed 7.9% ownership in Beam Therapeutics Inc. Common Stock (BEAM) on 30 Sep 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Jan 2025, 21:46.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC | 7.9% | 6,531,099 | 6,268,000 | 100,578 | /s/ Kellen Carter | Kellen Carter, Chief Compliance Officer |